Related Experiment Video
Updated: Jul 18, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
MRI-based Intra- and Peritumoral Heterogeneity in Hepatocellular Carcinoma for Microvascular Invasion Prediction and
Yunfei Zhang1,2, Shutong Wang3, Mingyue Song4
1Department of Radiology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.
This study introduces an MRI strategy to quantify tumor heterogeneity in hepatocellular carcinoma (HCC). The developed models accurately identify microvascular invasion (MVI) and predict patient prognosis.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Hepatocellular carcinoma (HCC) diagnosis and prognosis are challenging.
- Microvascular invasion (MVI) is a key prognostic factor in HCC.
- Quantifying tumor heterogeneity is crucial for improving diagnostic and prognostic models.
Purpose of the Study:
- To develop and evaluate an MRI-based strategy for quantifying intra-tumoral heterogeneity (ITH) and peritumoral heterogeneity (PTH) in HCC.
- To create ITH- and PTH-based models for diagnosing MVI and stratifying prognostic risk in HCC patients.
Main Methods:
- Retrospective analysis of HCC patients (≤5 cm) from three institutions.
- Unsupervised clustering to categorize tumor and peritumoral tissues into habitats on MR images.
- Extraction and quantification of radiomic features to represent ITH and PTH.
- Development of machine learning models (TH_DNN) for MVI diagnosis and survival analysis using Kaplan-Meier curves and Cox regression.
Main Results:
- The TH_DNN model, integrating ITH and PTH features, showed high predictive performance for MVI across datasets (AUC range: 0.82-0.99).
- Patients predicted as MVI-positive by the TH_DNN model had significantly poorer prognosis (overall survival and recurrence).
- Hazard ratios for MVI diagnosis were 2.79 for overall survival and 2.17 for postoperative recurrence.
Conclusions:
- The developed MRI-based strategy effectively quantifies ITH and PTH in HCC.
- This approach enables noninvasive and accurate identification of MVI.
- The strategy is valuable for prognostic risk stratification in HCC patients.
More Related Videos
10:25Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
Published on: April 12, 2024
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024